or Try an Advanced Search...

    Technical Analysis for NRBO - NeuroBo Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 2.40 0.00% 0.00
    NRBO closed down 2.04 percent on Wednesday, November 20, 2024, on 46 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NRBO trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Outside Day Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -2.04%
    Lower Bollinger Band Walk Weakness -2.04%
    Oversold Stochastic Weakness -2.04%
    NR7 Range Contraction 3.90%
    Narrow Range Bar Range Contraction 3.90%
    Lower Bollinger Band Walk Weakness 3.90%
    Inside Day Range Contraction 3.90%
    Older End-of-Day Signals for NRBO ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 2 hours ago
    Up 3% about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    Up 2% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NRBO Chart by TradingView
    Basic chart:

    Profile

    Researches and develops disease-modifying therapies for neurodegenerative diseases
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Organ Systems Neuroscience Stem Cell Neurodegenerative Diseases Degenerative Disease Neurodegeneration Senescence

    Is NRBO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases
    Nov 15 Life Sciences Investor Forum: Presentations Now Available for Online Viewing
    Nov 13 NeuroBo Pharmaceuticals to Participate in Investor Conferences in November
    Nov 13 NRBO: Topline Results for Phase 2a Trial of DA-1241 in MASH Expected in December 2024
    Nov 13 NRBO: Topline Results for Phase 2a Trial of DA-1241 in MASH Expected in December 2024...
    Nov 12 Life Sciences Investor Forum Agenda Announced for November 14th
    Nov 7 NeuroBo Pharmaceuticals GAAP EPS of -$0.55 beats by $0.18
    Nov 7 NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 4 NeuroBo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
    Oct 1 NRBO: Positive SAD Part 1 Data; MAD Part 2 Results Expected in 1Q25…
    See more NRBO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.7499
    52 Week Low 2.08
    Average Volume 47,579
    200-Day Moving Average 3.86
    50-Day Moving Average 2.85
    20-Day Moving Average 2.60
    10-Day Moving Average 2.50
    Average True Range 0.28
    RSI (14) 40.83
    ADX 10.62
    +DI 15.48
    -DI 18.76
    Chandelier Exit (Long, 3 ATRs) 2.29
    Chandelier Exit (Short, 3 ATRs) 3.01
    Upper Bollinger Bands 2.96
    Lower Bollinger Band 2.25
    Percent B (%b) 0.22
    BandWidth 27.25
    MACD Line -0.14
    MACD Signal Line -0.13
    MACD Histogram -0.0133
    Fundamentals Value
    Market Cap 11.64 Million
    Num Shares 4.85 Million
    EPS -43.82
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 0.00
    Price-to-Book 1.03
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.70
    Resistance 3 (R3) 2.70 2.60 2.65
    Resistance 2 (R2) 2.60 2.52 2.60 2.63
    Resistance 1 (R1) 2.50 2.48 2.45 2.50 2.62
    Pivot Point 2.40 2.40 2.38 2.40 2.40
    Support 1 (S1) 2.30 2.32 2.25 2.30 2.18
    Support 2 (S2) 2.20 2.28 2.20 2.17
    Support 3 (S3) 2.10 2.20 2.15
    Support 4 (S4) 2.10